v3.26.1
SIGNIFICANT ACCOUNTING POLICIES AND OTHER RISKS AND UNCERTAINTIES (Details Narrative)
3 Months Ended
Nov. 04, 2025
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
AUD ($)
Jun. 30, 2026
EUR (€)
Mar. 31, 2026
USD ($)
Product Information [Line Items]            
Net cash used in operating activities   $ (4,946,000) $ (4,526,000)      
Accumulated deficit   327,506,000       $ 319,571,000
Cash equivalents   9,800,000        
Cash deposit   3,400,000        
Restricted cash   $ 5,400,000       $ 5,600,000
Proceeds from issuance of secured promissory note $ 5,200,000          
Concentration risk benchmark description   As of June 30, 2026, the Company had greater than $250,000 at United States financial institutions, less than A$250,000 at Australian financial institutions, greater than €100,000 at Irish financial institutions and also has funds on deposit in Israel.        
Accounts Payable [Member] | Customer Concentration Risk [Member] | One Third Party Vendor [Member]            
Product Information [Line Items]            
Concentration percentage   90.00% 56.00%      
Accounts Payable [Member] | Customer Concentration Risk [Member] | Two Third-party Vendors [Member]            
Product Information [Line Items]            
Concentration percentage     89.00%      
Accounts Payable [Member] | Customer Concentration Risk [Member] | Two Third-party Vendor [Member]            
Product Information [Line Items]            
Concentration percentage     33.00%      
Australian Taxation Office [Member]            
Product Information [Line Items]            
Tax Rebate   $ 0 $ 0      
UNITED STATES            
Product Information [Line Items]            
Cash FDIC insured amount   250,000        
AUSTRALIA            
Product Information [Line Items]            
Cash FDIC insured amount       $ 250,000    
BERMUDA            
Product Information [Line Items]            
Cash FDIC insured amount   $ 25,000        
IRELAND            
Product Information [Line Items]            
Cash FDIC insured amount | €         € 100,000  
CYPRUS            
Product Information [Line Items]            
Cash FDIC insured amount | €         € 100,000  
Beyond Cancer Ltd [Member]            
Product Information [Line Items]            
Non-controlling owners interest   20.00%   20.00% 20.00%  
NeuroNos Ltd [Member]            
Product Information [Line Items]            
Non-controlling owners interest   28.40%   28.40% 28.40%